Viveve Medical, Inc. (VIVE)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2021 | 1.47 Million USD | -54.76% |
| 2020 | 3.25 Million USD | -33.06% |
| 2019 | 4.86 Million USD | 18.01% |
| 2018 | 4.11 Million USD | 72.34% |
| 2017 | 2.39 Million USD | -11.05% |
| 2016 | 2.68 Million USD | 73.47% |
| 2015 | 1.54 Million USD | 1082.44% |
| 2014 | 131 Thousand USD | 11.97% |
| 2013 | 117 Thousand USD | -35.71% |
| 2012 | 182 Thousand USD | -23.53% |
| 2011 | 238 Thousand USD | -71.53% |
| 2010 | 836 Thousand USD | -4.57% |
| 2009 | 876 Thousand USD | -22.89% |
| 2008 | 1.13 Million USD | 33.33% |
| 2007 | 852 Thousand USD | -32.11% |
| 2006 | 1.25 Million USD | 30.32% |
| 2005 | 963 Thousand USD | -13.4% |
| 2004 | 1.11 Million USD | 25.65% |
| 2003 | 885 Thousand USD | -2.96% |
| 2002 | 912 Thousand USD | -8.89% |
| 2001 | 1 Million USD | -30.49% |
| 2000 | 1.44 Million USD | -38.67% |
| 1999 | 2.34 Million USD | -21.73% |
| 1998 | 3 Million USD | 20.0% |
| 1997 | 2.5 Million USD | 8.7% |
| 1996 | 2.3 Million USD | 27.78% |
| 1995 | 1.8 Million USD | 38.46% |
| 1994 | 1.3 Million USD | -18.75% |
| 1993 | 1.6 Million USD | -20.0% |
| 1992 | 2 Million USD | 0.0% |
| 1991 | - USD | 0.0% |
| 1990 | - USD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2022 Q1 | 1.55 Million USD | 5.43% |
| 2022 Q3 | 1.61 Million USD | 1.0% |
| 2022 Q2 | 1.59 Million USD | 3.03% |
| 2021 Q4 | 1.47 Million USD | -31.53% |
| 2021 FY | 1.47 Million USD | -54.76% |
| 2021 Q1 | 3.04 Million USD | -6.3% |
| 2021 Q2 | 2.63 Million USD | -13.68% |
| 2021 Q3 | 2.15 Million USD | -18.31% |
| 2020 Q1 | 4.45 Million USD | -8.27% |
| 2020 Q3 | 4.59 Million USD | -6.63% |
| 2020 Q2 | 4.91 Million USD | 10.27% |
| 2020 FY | 3.25 Million USD | -33.06% |
| 2020 Q4 | 3.25 Million USD | -29.12% |
| 2019 Q1 | 3.86 Million USD | -6.12% |
| 2019 Q4 | 4.86 Million USD | 17.39% |
| 2019 FY | 4.86 Million USD | 18.01% |
| 2019 Q2 | 4.71 Million USD | 21.9% |
| 2019 Q3 | 4.14 Million USD | -12.16% |
| 2018 Q2 | 4.16 Million USD | 8.7% |
| 2018 Q1 | 3.82 Million USD | 60.17% |
| 2018 FY | 4.11 Million USD | 72.34% |
| 2018 Q4 | 4.11 Million USD | -8.41% |
| 2018 Q3 | 4.49 Million USD | 8.07% |
| 2017 Q1 | 2.38 Million USD | -11.31% |
| 2017 FY | 2.39 Million USD | -11.05% |
| 2017 Q4 | 2.39 Million USD | 25.59% |
| 2017 Q3 | 1.9 Million USD | -6.85% |
| 2017 Q2 | 2.04 Million USD | -14.27% |
| 2016 Q1 | 926 Thousand USD | -40.22% |
| 2016 Q2 | 845 Thousand USD | -8.75% |
| 2016 Q3 | 1.41 Million USD | 67.22% |
| 2016 Q4 | 2.68 Million USD | 90.16% |
| 2016 FY | 2.68 Million USD | 73.47% |
| 2015 Q3 | 645 Thousand USD | 91.39% |
| 2015 FY | 1.54 Million USD | 1082.44% |
| 2015 Q1 | 167 Thousand USD | 27.48% |
| 2015 Q4 | 1.54 Million USD | 140.16% |
| 2015 Q2 | 337 Thousand USD | 101.8% |
| 2014 Q4 | 131 Thousand USD | -4.31% |
| 2014 Q3 | 136.9 Thousand USD | 35.55% |
| 2014 Q2 | 101 Thousand USD | -9.82% |
| 2014 Q1 | 112 Thousand USD | -4.27% |
| 2014 FY | 131 Thousand USD | 11.97% |
| 2013 Q1 | 89 Thousand USD | -51.1% |
| 2013 Q3 | 145 Thousand USD | -9.94% |
| 2013 Q2 | 161 Thousand USD | 80.9% |
| 2013 FY | 117 Thousand USD | -35.71% |
| 2013 Q4 | 117 Thousand USD | -19.31% |
| 2012 Q1 | 219 Thousand USD | -7.98% |
| 2012 Q4 | 182 Thousand USD | -22.55% |
| 2012 Q3 | 235 Thousand USD | 17.5% |
| 2012 Q2 | 200 Thousand USD | -8.68% |
| 2012 FY | 182 Thousand USD | -23.53% |
| 2011 FY | 238 Thousand USD | -71.53% |
| 2011 Q4 | 238 Thousand USD | 19.0% |
| 2011 Q3 | 200 Thousand USD | 29.87% |
| 2011 Q2 | 154 Thousand USD | -52.91% |
| 2011 Q1 | 327 Thousand USD | -60.89% |
| 2010 Q4 | 836 Thousand USD | 6.91% |
| 2010 Q1 | 801 Thousand USD | -8.56% |
| 2010 FY | 836 Thousand USD | -4.57% |
| 2010 Q2 | 795 Thousand USD | -0.75% |
| 2010 Q3 | 782 Thousand USD | -1.64% |
| 2009 FY | 876 Thousand USD | -22.89% |
| 2009 Q1 | 1.03 Million USD | -9.33% |
| 2009 Q2 | 978 Thousand USD | -5.05% |
| 2009 Q3 | 945 Thousand USD | -3.37% |
| 2009 Q4 | 876 Thousand USD | -7.3% |
| 2008 Q1 | 1.43 Million USD | 68.19% |
| 2008 Q2 | 1.41 Million USD | -1.05% |
| 2008 Q4 | 1.13 Million USD | -0.7% |
| 2008 FY | 1.13 Million USD | 33.33% |
| 2008 Q3 | 1.14 Million USD | -19.32% |
| 2007 FY | 852 Thousand USD | -32.11% |
| 2007 Q2 | 990 Thousand USD | -8.08% |
| 2007 Q4 | 852 Thousand USD | -0.35% |
| 2007 Q3 | 855 Thousand USD | -13.64% |
| 2007 Q1 | 1.07 Million USD | -14.18% |
| 2006 Q2 | 986 Thousand USD | -1.0% |
| 2006 Q1 | 996 Thousand USD | 3.43% |
| 2006 FY | 1.25 Million USD | 30.32% |
| 2006 Q4 | 1.25 Million USD | 7.82% |
| 2006 Q3 | 1.16 Million USD | 18.05% |
| 2005 Q1 | 1.27 Million USD | 15.02% |
| 2005 Q4 | 963 Thousand USD | -2.23% |
| 2005 Q2 | 1.14 Million USD | -10.4% |
| 2005 FY | 963 Thousand USD | -13.4% |
| 2005 Q3 | 985 Thousand USD | -14.05% |
| 2004 Q3 | 1.33 Million USD | 16.38% |
| 2004 FY | 1.11 Million USD | 25.65% |
| 2004 Q1 | 836 Thousand USD | -5.54% |
| 2004 Q2 | 1.14 Million USD | 37.32% |
| 2004 Q4 | 1.11 Million USD | -16.77% |
| 2003 FY | 885 Thousand USD | -2.96% |
| 2003 Q4 | 885 Thousand USD | -20.98% |
| 2003 Q3 | 1.12 Million USD | 2.28% |
| 2003 Q2 | 1.09 Million USD | 3.5% |
| 2003 Q1 | 1.05 Million USD | 16.01% |
| 2002 Q2 | 946 Thousand USD | 9.24% |
| 2002 Q1 | 866 Thousand USD | -13.49% |
| 2002 FY | 912 Thousand USD | -8.89% |
| 2002 Q4 | 912 Thousand USD | 0.66% |
| 2002 Q3 | 906 Thousand USD | -4.23% |
| 2001 Q3 | 1.31 Million USD | -0.23% |
| 2001 Q2 | 1.32 Million USD | -10.13% |
| 2001 Q1 | 1.47 Million USD | 2.15% |
| 2001 FY | 1 Million USD | -30.49% |
| 2001 Q4 | 1 Million USD | -24.11% |
| 2000 Q4 | 1.44 Million USD | -14.54% |
| 2000 Q2 | 1.82 Million USD | -14.09% |
| 2000 Q1 | 2.12 Million USD | -9.63% |
| 2000 FY | 1.44 Million USD | -38.67% |
| 2000 Q3 | 1.68 Million USD | -7.57% |
| 1999 Q3 | 1.6 Million USD | -27.27% |
| 1999 FY | 2.34 Million USD | -21.73% |
| 1999 Q1 | 3 Million USD | 0.0% |
| 1999 Q2 | 2.2 Million USD | -26.67% |
| 1999 Q4 | 2.34 Million USD | 46.75% |
| 1998 Q2 | 3.9 Million USD | 30.0% |
| 1998 Q4 | 3 Million USD | -23.08% |
| 1998 Q3 | 3.9 Million USD | 0.0% |
| 1998 Q1 | 3 Million USD | 20.0% |
| 1998 FY | 3 Million USD | 20.0% |
| 1997 Q2 | 3.1 Million USD | -3.13% |
| 1997 Q3 | 3.2 Million USD | 3.23% |
| 1997 Q4 | 2.5 Million USD | -21.88% |
| 1997 FY | 2.5 Million USD | 8.7% |
| 1997 Q1 | 3.2 Million USD | 39.13% |
| 1996 Q2 | 2.9 Million USD | 45.0% |
| 1996 Q3 | 3.2 Million USD | 10.34% |
| 1996 Q4 | 2.3 Million USD | -28.13% |
| 1996 FY | 2.3 Million USD | 27.78% |
| 1996 Q1 | 2 Million USD | 11.11% |
| 1995 FY | 1.8 Million USD | 38.46% |
| 1995 Q4 | 1.8 Million USD | 0.0% |
| 1994 Q2 | 1.6 Million USD | 14.29% |
| 1994 Q3 | 1.5 Million USD | -6.25% |
| 1994 FY | 1.3 Million USD | -18.75% |
| 1994 Q4 | 1.3 Million USD | -13.33% |
| 1994 Q1 | 1.4 Million USD | -12.5% |
| 1993 Q2 | 2.4 Million USD | 14.29% |
| 1993 Q4 | 1.6 Million USD | -27.27% |
| 1993 Q3 | 2.2 Million USD | -8.33% |
| 1993 FY | 1.6 Million USD | -20.0% |
| 1993 Q1 | 2.1 Million USD | 5.0% |
| 1992 FY | 2 Million USD | 0.0% |
| 1992 Q3 | 2.5 Million USD | 4.17% |
| 1992 Q4 | 2 Million USD | -20.0% |
| 1992 Q2 | 2.4 Million USD | 26.32% |
| 1992 Q1 | 1.9 Million USD | 0.0% |
| 1991 FY | - USD | 0.0% |
| 1991 Q4 | - USD | 0.0% |
| 1990 FY | - USD | 0.0% |
| 1990 Q4 | - USD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 3.31 Million USD | 55.529% |
| BrainsWay Ltd. | 3.71 Million USD | 60.398% |
| Cerus Corporation | 39.86 Million USD | 96.308% |
| Envoy Medical, Inc. | 1.4 Million USD | -4.843% |
| electroCore, Inc. | 2.16 Million USD | 31.852% |
| Helius Medical Technologies, Inc. | 457 Thousand USD | -222.101% |
| IceCure Medical Ltd | 2.27 Million USD | 35.297% |
| Inogen, Inc. | 21.84 Million USD | 93.26% |
| OrthoPediatrics Corp. | 105.85 Million USD | 98.609% |
| Lucid Diagnostics Inc. | 278 Thousand USD | -429.496% |
| Monogram Orthopaedics, Inc. | 1.00 USD | -147199900.0% |
| MaxCyte, Inc. | 12.22 Million USD | 87.963% |
| NeuroOne Medical Technologies Corporation | 1.72 Million USD | 14.75% |
| Nexalin Technology, Inc. | 156.42 Thousand USD | -841.056% |
| Orthofix Medical Inc. | 222.16 Million USD | 99.337% |
| PAVmed Inc | 1.01 Million USD | -44.74% |
| Rapid Micro Biosystems, Inc. | 19.96 Million USD | 92.626% |
| RxSight, Inc. | 17.42 Million USD | 91.55% |
| Sight Sciences, Inc. | 7.84 Million USD | 81.246% |
| SI-BONE, Inc. | 20.24 Million USD | 92.731% |
| TELA Bio, Inc. | 13.16 Million USD | 88.816% |
| Treace Medical Concepts, Inc. | 29.24 Million USD | 94.967% |
| Vivos Therapeutics, Inc. | 1.00 USD | -147199900.0% |
| Acutus Medical, Inc. | 4.27 Million USD | 65.591% |
| Talis Biomedical Corporation | - USD | -Infinity% |
| Spectral AI, Inc. | 230 Thousand USD | -540.0% |
| Nano-X Imaging Ltd. | 2.35 Million USD | 37.521% |
| CVRx, Inc. | 10.98 Million USD | 86.597% |
| DIH Holding US, Inc. Warrants | - USD | -Infinity% |
| PetVivo Holdings, Inc. | 390.07 Thousand USD | -277.362% |
| Bioventus Inc. | 91.33 Million USD | 98.388% |
| Venus Concept Inc. | 28.67 Million USD | 94.867% |
| TriSalus Life Sciences, Inc. | 2.54 Million USD | 42.161% |
| LivaNova PLC | 147.88 Million USD | 99.005% |
| 908 Devices Inc. | 14.93 Million USD | 90.146% |
| Alphatec Holdings, Inc. | 136.84 Million USD | 98.924% |
| Nemaura Medical Inc. | 1.75 Million USD | 16.118% |
| NeuroPace, Inc. | 11.21 Million USD | 86.874% |
| LENSAR, Inc. | 15.68 Million USD | 90.618% |
| Apyx Medical Corporation | 9.92 Million USD | 85.166% |
| Cutera, Inc. | 72.1 Million USD | 97.958% |
| STRATA Skin Sciences, Inc. | 2.67 Million USD | 44.931% |
| BioSig Technologies, Inc. | -103 Thousand USD | 1529.126% |
| Anika Therapeutics, Inc. | 46.38 Million USD | 96.827% |
| ClearPoint Neuro, Inc. | 7.91 Million USD | 81.393% |
| Integra LifeSciences Holdings Corporation | 389.6 Million USD | 99.622% |
| Axonics, Inc. | 79.94 Million USD | 98.159% |
| Outset Medical, Inc. | 49.21 Million USD | 97.009% |
| IRIDEX Corporation | 9.9 Million USD | 85.14% |
| PROCEPT BioRobotics Corporation | 39.75 Million USD | 96.297% |
| IRadimed Corporation | 12.82 Million USD | 88.519% |
| Tivic Health Systems, Inc. | 756 Thousand USD | -94.709% |
| INVO Bioscience, Inc. | 264.5 Thousand USD | -456.507% |
| Telesis Bio, Inc. | 4.02 Million USD | 63.429% |
| Viemed Healthcare, Inc. | 4.6 Million USD | 68.03% |
| Varex Imaging Corporation | 277.5 Million USD | 99.47% |
| Quipt Home Medical Corp. | 18.32 Million USD | 91.968% |
| Inspira Technologies Oxy B.H.N. Ltd. | - USD | -Infinity% |
| Pulmonx Corporation | 16.74 Million USD | 91.208% |
| Dynatronics Corporation | 5.59 Million USD | 73.686% |
| Modular Medical, Inc. | - USD | -Infinity% |
| ReShape Lifesciences Inc. | 3.74 Million USD | 60.652% |
| Semler Scientific, Inc. | 445 Thousand USD | -230.787% |
| InMode Ltd. | 45.09 Million USD | 96.736% |
| Bruker Corporation | 968.3 Million USD | 99.848% |
| Cytosorbents Corporation | 3.68 Million USD | 60.001% |
| DexCom, Inc. | 559.6 Million USD | 99.737% |
| Align Technology, Inc. | 296.9 Million USD | 99.504% |
| ZimVie Inc. | 79.6 Million USD | 98.151% |
| Movano Inc. | 1.51 Million USD | 2.71% |
| Cytek Biosciences, Inc. | 60.87 Million USD | 97.582% |
| Nexalin Technology, Inc. | 156.42 Thousand USD | -841.056% |
| DIH Holdings US, Inc. Class A Common Stock | - USD | -Infinity% |
| Tandem Diabetes Care, Inc. | 157.93 Million USD | 99.068% |
| Profound Medical Corp. | 6.95 Million USD | 78.83% |
| Insulet Corporation | 402.6 Million USD | 99.634% |
| enVVeno Medical Corporation | - USD | -Infinity% |
| Surmodics, Inc. | 14.83 Million USD | 90.08% |
| iCAD, Inc. | 917 Thousand USD | -60.523% |
| Nuwellis, Inc. | 1.99 Million USD | 26.289% |
| Biotricity, Inc. | 1.87 Million USD | 21.677% |
| iRhythm Technologies, Inc. | 13.97 Million USD | 89.465% |
| Aethlon Medical, Inc. | - USD | -Infinity% |
| InspireMD, Inc. | 2.1 Million USD | 30.104% |
| PAVmed Inc. | 1.01 Million USD | -44.74% |
| BIOLASE, Inc. | 11.43 Million USD | 87.125% |
| Beyond Air, Inc. | 2.12 Million USD | 30.795% |
| FONAR Corporation | 2.71 Million USD | 45.791% |
| AxoGen, Inc. | 23.02 Million USD | 93.606% |
| Vivani Medical, Inc. | - USD | -Infinity% |
| Tactile Systems Technology, Inc. | 22.52 Million USD | 93.466% |
| Inari Medical, Inc. | 42.9 Million USD | 96.569% |
| UFP Technologies, Inc. | 70.19 Million USD | 97.903% |
| QT Imaging Holdings, Inc. | - USD | -Infinity% |
| Heart Test Laboratories, Inc. | 629.17 Thousand USD | -133.956% |
| Tenon Medical, Inc. | 554 Thousand USD | -165.704% |
| Autonomix Medical, Inc. Common Stock | - USD | -Infinity% |
| Co-Diagnostics, Inc. | 1.66 Million USD | 11.577% |
| AdaptHealth Corp. | 113.64 Million USD | 98.705% |
| Sintx Technologies, Inc. | 888 Thousand USD | -65.766% |
| NanoVibronix, Inc. | 2.73 Million USD | 46.12% |
| Quanterix Corporation | 22.36 Million USD | 93.418% |
| Inspira Technologies Oxy B.H.N. Ltd. | - USD | -Infinity% |
| Sensus Healthcare, Inc. | 14.84 Million USD | 90.086% |
| Pacific Biosciences of California, Inc. | 56.67 Million USD | 97.403% |
| TransMedics Group, Inc. | 44.23 Million USD | 96.672% |
| ReWalk Robotics Ltd. | 5.65 Million USD | 73.961% |
| NeuroMetrix, Inc. | 1.55 Million USD | 5.606% |
| Hyperfine, Inc. | 6.58 Million USD | 77.636% |
| Establishment Labs Holdings Inc. | 79.93 Million USD | 98.159% |
| Biomerica, Inc. | 2.37 Million USD | 38.047% |
| Bone Biologics Corporation | -328.84 Thousand USD | 547.629% |
| AVITA Medical, Inc. | 3.12 Million USD | 52.842% |
| Bluejay Diagnostics, Inc. | - USD | -Infinity% |
| Silk Road Medical, Inc | 29.87 Million USD | 95.073% |